Clinical Impact of Laboratory Implementation of Verigene BC-GN Microarray-Based Assay for Detection of Gram-Negative Bacteria in Positive Blood Cultures
|
Material Type |
Article
|
Author(s) |
Walker, Tamar (Author)
Dumadag, Sandrea (Author)
|
Source Journal Info. |
Title:
Journal of Clinical Microbiology
|
|
Volume/ Issue No.: 2016/JUL V.54 N.7
Call No.:616.0105 JCM Location: Periodicals & References Hall - 2nd floor
|
Physical Description |
p 1789-1796
|
Subject Area/ Descriptors |
Medical sciences
(12461)
|
|
|
Abstract |
Gram-negative bacteremia is highly fatal, and hospitalizations due to sepsis have been increasing worldwide. Molecular tests that supplement Gram stain results from positive blood cultures provide specific organism information to potentially guide therapy, but more clinical data on their real-world impact are still needed. We retrospectively reviewed cases of Gram-negative bacteremia in hospitalized patients over a 6-month period before (n = 98) and over a 6-month period after (n = 97) the implementation of a microarray-based early identification and resistance marker detection system (Verigene BC-GN; Nanosphere) while antimicrobial stewardship practices remained constant. Patient demographics, time to organism identification, time to effective antimicrobial therapy...
Full Abstract
|
| More Articles from:
Journal:
Journal of Clinical Microbiology
(3691)
Issu: 2016/JUL V.54 N.7
|
|
|
|
|